Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 456

1.

Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata.

Vallerand IA, Lewinson RT, Parsons LM, Hardin J, Haber RM, Lowerison MW, Barnabe C, Patten SB.

JAMA Dermatol. 2019 Jan 16. doi: 10.1001/jamadermatol.2018.4398. [Epub ahead of print]

PMID:
30649133
2.

Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.

Whitehouse CE, Fisk JD, Bernstein CN, Berrigan LI, Bolton JM, Graff LA, Hitchon CA, Marriott JJ, Peschken CA, Sareen J, Walker JR, Stewart SH, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006854. doi: 10.1212/WNL.0000000000006854. [Epub ahead of print]

PMID:
30635487
3.

The "Clinician's illusion" and the epidemiology, diagnosis and treatment of depressive disorders.

Patten SB.

BMC Psychiatry. 2018 Dec 20;18(1):395. doi: 10.1186/s12888-018-1969-3.

4.

"Vitiligo and major depressive disorder: a bidirectional population-based cohort study".

Vallerand IA, Lewinson RT, Parsons LM, Hardin J, Haber RM, Lowerison MW, Barnabe C, Patten SB.

J Am Acad Dermatol. 2018 Dec 5. pii: S0190-9622(18)32982-7. doi: 10.1016/j.jaad.2018.11.047. [Epub ahead of print]

PMID:
30528503
5.

Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis.

Benedetti A, Wu Y, Levis B, Wilchesky M, Boruff J, Ioannidis JPA, Patten SB, Cuijpers P, Shrier I, Gilbody S, Ismail Z, McMillan D, Mitchell N, Ziegelstein RC, Thombs BD.

BMJ Open. 2018 Dec 4;8(12):e026598. doi: 10.1136/bmjopen-2018-026598.

6.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8.

7.

Global Burden of Disease Study trends for Canada from 1990 to 2016.

Lang JJ, Alam S, Cahill LE, Drucker AM, Gotay C, Kayibanda JF, Kozloff N, Mate KKV, Patten SB, Orpana HM.

CMAJ. 2018 Nov 5;190(44):E1296-E1304. doi: 10.1503/cmaj.180698.

8.

Patient satisfaction with epilepsy surgery: what is important to patients?

Lunney M, Wahby S, Sauro KM, Atkinson MJ, Josephson CB, Girgis F, Singh S, Patten SB, Jetté N, Sajobi TT, Hader W, Wiebe S.

Epileptic Disord. 2018 Oct 1;20(5):364-373. doi: 10.1684/epd.2018.0995.

PMID:
30361186
9.

Increasing rates of arthroplasty for psoriatic arthritis in the United Kingdom between 1995 and 2010.

Lewinson RT, Vallerand IA, LaMothe JM, Parsons LM, Frolkis AD, Lowerison MW, Patten SB, Barnabe C.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23793. [Epub ahead of print]

PMID:
30354036
10.

Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression.

Frolkis AD, Vallerand IA, Shaheen AA, Lowerison MW, Swain MG, Barnabe C, Patten SB, Kaplan GG.

Gut. 2018 Oct 18. pii: gutjnl-2018-317182. doi: 10.1136/gutjnl-2018-317182. [Epub ahead of print]

PMID:
30337374
11.

Adherence to and Persistence with Antidepressant Medication during Pregnancy: Does It Differ by the Class of Antidepressant Medication Prescribed?

Adhikari K, Patten SB, Lee S, Metcalfe A.

Can J Psychiatry. 2018 Sep 25:706743718802809. doi: 10.1177/0706743718802809. [Epub ahead of print]

PMID:
30252505
12.

Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review.

Gasim M, Bernstein CN, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Marriott JJ, Fisk JD, Marrie RA; CIHR team “Defining the burden and managing the effects of psychiatric comorbidity in chronic inflammatory disease”.

Mult Scler Relat Disord. 2018 Nov;26:124-156. doi: 10.1016/j.msard.2018.09.008. Epub 2018 Sep 12. Review.

13.

Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4.

Ishihara M, Harel D, Levis B, Levis AW, Riehm KE, Saadat N, Azar M, Rice DB, Sanchez TA, Chiovitti MJ, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Arroll B, Bombardier CH, Butterworth P, Carter G, Clover K, Conwell Y, Goodyear-Smith F, Greeno CG, Hambridge J, Harrison PA, Hudson M, Jetté N, Kiely KM, McGuire A, Pence BW, Rooney AG, Sidebottom A, Simning A, Turner A, White J, Whooley MA, Winkley K, Benedetti A, Thombs BD.

Depress Anxiety. 2019 Jan;36(1):82-92. doi: 10.1002/da.22841. Epub 2018 Sep 20.

PMID:
30238571
14.

Major depressive episodes and mortality in the Canadian household population.

Patten SB, Williams JV, Bulloch AG.

J Affect Disord. 2019 Jan 1;242:165-171. doi: 10.1016/j.jad.2018.08.030. Epub 2018 Aug 14.

PMID:
30179790
15.

Factors associated with perceived need for mental health care in multiple sclerosis.

Orr J, Bernstein CN, Graff LA, Patten SB, Bolton JM, Sareen J, Marriott JJ, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Mult Scler Relat Disord. 2018 Oct;25:179-185. doi: 10.1016/j.msard.2018.07.043. Epub 2018 Jul 29.

16.

The effect of child hunger on educational attainment and early childbearing outcomes in a longitudinal population sample of Canadian youth.

McIntyre L, Kwok C, Patten SB.

Paediatr Child Health. 2018 Aug;23(5):e77-e84. doi: 10.1093/pch/pxx177. Epub 2017 Dec 22.

PMID:
30046272
17.

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study.

Vallerand IA, Lewinson RT, Frolkis AD, Lowerison MW, Kaplan GG, Swain MG, Bulloch AGM, Patten SB, Barnabe C.

RMD Open. 2018 Jul 11;4(2):e000670. doi: 10.1136/rmdopen-2018-000670. eCollection 2018.

18.

Safety of psychotropic medicines: looking beyond randomised evidence.

Barbui C, Patten SB.

Epidemiol Psychiatr Sci. 2018 Dec;27(6):529-530. doi: 10.1017/S2045796018000306. Epub 2018 Jul 13. No abstract available.

PMID:
30001764
19.

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study.

Hirsch L, Patten SB, Bresee L, Jette N, Pringsheim T.

BJPsych Open. 2018 Jul;4(4):256-261. doi: 10.1192/bjo.2018.33.

20.

Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.

Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, Graff LA, Patten SB, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Inflamm Bowel Dis. 2019 Jan 10;25(2):360-368. doi: 10.1093/ibd/izy235.

PMID:
29986021
21.

Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.

Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Jul - Aug;53:65-72. doi: 10.1016/j.genhosppsych.2018.06.001. Epub 2018 Jun 7.

22.

Social support and maternal mental health at 4 months and 1 year postpartum: analysis from the All Our Families cohort.

Hetherington E, McDonald S, Williamson T, Patten SB, Tough SC.

J Epidemiol Community Health. 2018 Oct;72(10):933-939. doi: 10.1136/jech-2017-210274. Epub 2018 Jun 19.

PMID:
29921649
23.

Psoriasis and the risk of foot and ankle tendinopathy or enthesopathy in the absence of psoriatic arthritis: a population-based study.

Lewinson RT, Vallerand IA, Parsons LM, LaMothe JM, Frolkis AD, Lowerison MW, Kaplan GG, Patten SB, Barnabe C.

RMD Open. 2018 May 21;4(1):e000668. doi: 10.1136/rmdopen-2018-000668. eCollection 2018.

24.

Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.

McKay KA, Marrie RA, Fisk JD, Patten SB, Tremlett H.

Neuroepidemiology. 2018;51(1-2):1-10. doi: 10.1159/000488799. Epub 2018 May 15.

PMID:
29763935
25.

Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice.

Josephson CB, Engbers JDT, Jette N, Patten SB, Sajobi TT, Marshall D, Lowerison M, Wiebe S.

Epilepsy Behav. 2018 Jul;84:49-55. doi: 10.1016/j.yebeh.2018.04.012. Epub 2018 May 9.

PMID:
29753294
26.

Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews.

Levis B, Benedetti A, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Chiovitti MJ, Sanchez TA, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Steele RJ, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Beraldi A, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Chowdhary N, Clover K, Conwell Y, de Man-van Ginkel JM, Delgadillo J, Fann JR, Fischer FH, Fischler B, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Hambridge J, Harrison PA, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki M, Ismail K, Jetté N, Khamseh ME, Kiely KM, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, Marsh L, McGuire A, Mohd Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van der Feltz-Cornelis CM, van Weert HC, Vöhringer PA, White J, Whooley MA, Winkley K, Yamada M, Zhang Y, Thombs BD.

Br J Psychiatry. 2018 Jun;212(6):377-385. doi: 10.1192/bjp.2018.54. Epub 2018 May 2.

PMID:
29717691
27.

Effects of depression and anxiety on quality of life in five common neurological disorders.

Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N.

Gen Hosp Psychiatry. 2018 May - Jun;52:58-63. doi: 10.1016/j.genhosppsych.2018.03.009. Epub 2018 Apr 4.

PMID:
29684713
28.

Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis.

Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, Leung S, Fiest KM, McKay KA, Fisk JD; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2018 Mar-Apr;20(2):76-84. doi: 10.7224/1537-2073.2016-110.

29.

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Inflamm Bowel Dis. 2018 Apr 13. doi: 10.1093/ibd/izy068. [Epub ahead of print]

PMID:
29668911
30.

Depressive Symptomatology, Syndromal Depression, and HIV-Associated Neurocognitive Disorder (HAND).

Goodkin K, Patten SB.

Can J Psychiatry. 2018 May;63(5):284-286. doi: 10.1177/0706743718754537. No abstract available.

31.

Is depression screening in patients with acne critical?: reply from authors.

Vallerand IA, Lewinson RT, Parsons LM, Lowerison MW, Frolkis AD, Kaplan GG, Barnabe C, Bulloch AGM, Patten SB.

Br J Dermatol. 2018 Jul;179(1):227-228. doi: 10.1111/bjd.16673. Epub 2018 May 27. No abstract available.

PMID:
29654704
32.

Validating screening tools for depression in Parkinson's disease.

Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, Gill S, Bulloch AGM, Hu B, Jette N.

Mov Disord. 2018 Jul;33(7):1184-1186. doi: 10.1002/mds.27371. Epub 2018 Mar 24. No abstract available.

PMID:
29573354
33.

Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2018 Apr 10;90(15):e1316-e1323. doi: 10.1212/WNL.0000000000005302. Epub 2018 Mar 9.

PMID:
29523642
34.

Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.

Litster B, Bernstein CN, Graff LA, Walker JR, Fisk JD, Patten SB, Bolton JM, Sareen J, El-Gabalawy R, Marrie RA.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1641-1648. doi: 10.1093/ibd/izy032.

PMID:
29522100
35.

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.

Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):970-978. doi: 10.1002/acr.23539. Epub 2018 May 21.

36.

Risk of depression among patients with acne in the U.K.: a population-based cohort study.

Vallerand IA, Lewinson RT, Parsons LM, Lowerison MW, Frolkis AD, Kaplan GG, Barnabe C, Bulloch AGM, Patten SB.

Br J Dermatol. 2018 Mar;178(3):e194-e195. doi: 10.1111/bjd.16099. Epub 2018 Feb 7. No abstract available.

PMID:
29411352
37.

Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Mar - Apr;51:71-78. doi: 10.1016/j.genhosppsych.2018.01.003. Epub 2018 Jan 11.

PMID:
29353127
38.

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Marrie RA, Graff L, Walker JR, Fisk JD, Patten SB, Hitchon CA, Lix LM, Bolton J, Sareen J, Katz A, Berrigan LI, Marriott JJ, Singer A, El-Gabalawy R, Peschken CA, Zarychanski R, Bernstein CN.

JMIR Res Protoc. 2018 Jan 17;7(1):e15. doi: 10.2196/resprot.8794.

39.

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott JJ, Bernstein CN.

Mult Scler Relat Disord. 2018 Feb;20:9-15. doi: 10.1016/j.msard.2017.12.007. Epub 2017 Dec 16.

40.

Discriminative ability of quality of life measures in multiple sclerosis.

Fiest KM, Greenfield J, Metz LM, Patten SB, Jetté N, Marrie RA.

Health Qual Life Outcomes. 2017 Dec 21;15(1):246. doi: 10.1186/s12955-017-0828-0.

41.

Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care.

Turcotte LA, Marrie RA, Patten SB, Hirdes JP.

Can J Neurol Sci. 2018 Mar;45(2):188-198. doi: 10.1017/cjn.2017.274. Epub 2017 Dec 18.

PMID:
29251260
42.

Featured Canadian Research on Child, Adolescent, and Young Adult Psychiatry.

Patten SB.

Can J Psychiatry. 2017 Dec;62(12):810-812. doi: 10.1177/0706743717742864. No abstract available.

43.

Online tools for individuals with depression and neurologic conditions: A scoping review.

Lukmanji S, Pham T, Blaikie L, Clark C, Jetté N, Wiebe S, Bulloch A, Holroyd-Leduc J, Macrodimitris S, Mackie A, Patten SB.

Neurol Clin Pract. 2017 Aug;7(4):344-353. doi: 10.1212/CPJ.0000000000000365. Review.

44.

Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it.

Jetté N, Amoozegar F, Patten SB.

Neurol Clin Pract. 2017 Apr;7(2):118-127. doi: 10.1212/CPJ.0000000000000349. Review.

45.

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

BMC Res Notes. 2017 Nov 25;10(1):619. doi: 10.1186/s13104-017-2958-1.

46.

The prevalence of anxiety and associated factors in persons with multiple sclerosis.

Pham T, Jetté N, Bulloch AGM, Burton JM, Wiebe S, Patten SB.

Mult Scler Relat Disord. 2018 Jan;19:35-39. doi: 10.1016/j.msard.2017.11.003.

PMID:
29125968
47.

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.

Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Neurology. 2017 Dec 12;89(24):2455-2461. doi: 10.1212/WNL.0000000000004716. Epub 2017 Nov 8.

48.

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Epidemiol Psychiatr Sci. 2017 Nov 3:1-10. doi: 10.1017/S2045796017000579. [Epub ahead of print]

PMID:
29098977
49.

Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship.

Vallerand IA, Patten SB.

Br J Dermatol. 2018 Jan;178(1):305. doi: 10.1111/bjd.16018. Epub 2018 Jan 10. No abstract available.

PMID:
28975606

Supplemental Content

Loading ...
Support Center